Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,073 total articles
Senseonics Holdings, Inc. reported new real-world data at the American Diabetes Association Scientific Sessions showcasing the strong performance and patient adherence of its Eversense 365 implantable continuous glucose monitoring (CGM) system. The data from over 12,000 sensors confirm sustained accuracy and positive glycemic outcomes over a full y…
All In FutureTech Alliance (Nasdaq: AIFA) provided a strategic update on accelerating its transformation into an AI infrastructure platform leveraging optical technologies. Key developments include expanding the Hainan AIFA Silicon Photonics Supercomputing Center project into a broader Digital Industrial Park, progressing in governmental approvals …
Cullinan Therapeutics reported initial Phase 1 clinical data for CLN-978, a CD19xCD3 T cell engager, showing clinical benefit including remissions in patients with refractory systemic lupus erythematosus (SLE) and difficult-to-treat rheumatoid arthritis (RA). Data demonstrated deep, dose-dependent B cell depletion in blood and tissue along with a f…
InterPrivate Investment Partners V, Inc., a blank check company focused on mergers and acquisitions, has closed its initial public offering of 20,125,000 units at $10 per unit, raising $201.25 million before expenses. The units began trading on Nasdaq under the ticker symbol IPVVU, with plans to list their Class A shares and warrants separately in …
Bluejay Diagnostics has closed an $8.5 million private placement priced at-the-market on Nasdaq, with potential to raise an additional $15.2 million through warrant exercises. The proceeds are expected to extend the company's cash runway into Q1 2027, supporting FDA submission and subsequent commercialization of its near-patient sepsis testing prod…
MannKind Corporation announced new clinical and real-world data on Afrezza, its inhaled insulin product, at the ADA 2026 Scientific Sessions. The data build on the recent FDA approval for pediatric use and highlight Afrezza’s safety, efficacy, and patient treatment satisfaction in children, adolescents, and gestational diabetes patients. Additional…
Biomea Fusion presented promising clinical and translational data for its oral menin inhibitor icovamenib at the ADA 86th Scientific Sessions, demonstrating benefits in type 1 and type 2 diabetes including improved insulin secretion, glycemic control, muscle preservation, and fat reduction. Additionally, the company announced expansion of its Phase…
Kailera Therapeutics and Hengrui Pharma announced encouraging clinical results for ribupatide, a GLP-1/GIP dual agonist, in both oral and injectable forms for obesity treatment. Phase 2 data from Hengrui showed up to 12.1% mean weight loss with the oral pill over 26 weeks with favorable tolerability. Kailera's Phase 1 trial of the injection demonst…
B2Gold Corp., an international gold producer, reported the results of its 2026 Annual General and Special Meeting held on June 4, 2026. Shareholders voted overwhelmingly in favor of all business items, including the election of ten directors, appointment of PricewaterhouseCoopers LLP as auditor, approval of the Restricted Share Unit Plan, and advis…
Grupo Aeroportuario del Pacifico, which operates 12 airports in Mexico and two in Jamaica, reported a 4.1% decrease in total passenger traffic in May 2026 compared to May 2025. The decline was driven by decreases at key airports including Puerto Vallarta, Tijuana, Los Cabos, and Montego Bay, despite a passenger increase at Guadalajara airport. Avai…
Caliber (Nasdaq: CWD), a real estate and digital asset management platform, announced the departure of long-time CFO Jade Leung and appointed Michael Rosales as Acting CFO effective June 14, 2026. The company reaffirmed its 2026 financial guidance and emphasized that the CFO transition will not impact its strategy or outlook. A search for a permane…
BCB Bancorp, Inc., holding company of BCB Community Bank, announced the granting of 709,220 shares of restricted common stock to its newly appointed CEO and President, Thomas M. O’Brien, as an inducement under Nasdaq Listing Rule 5635(c)(4). The restricted shares vest over five years, contingent on continued service.
Century Aluminum's CEO Jesse Gary will present at the Wells Fargo Industrials and Materials Conference on June 9, 2026, discussing company operations, market conditions, and forward-looking plans including new smelter projects and operational challenges.
dLocal Limited, a cross-border payment platform focused on emerging markets, announced it will release its second quarter 2026 financial results on August 13, 2026, followed by a conference call and webcast. The company facilitates global payment infrastructures connecting enterprises to local markets in Africa, Asia, the Middle East, and Latin Ame…
DBV Technologies announced that CEO Daniel Tassé will participate in a fireside chat at the upcoming Goldman Sachs 47th Annual Global Healthcare Conference. The company is advancing its proprietary VIASKIN® patch technology for treating food allergies, focusing on clinical trials for peanut allergy in young children. The event will be webcast live …
Artisan Partners Asset Management Inc. announced preliminary assets under management (AUM) totaling $186.0 billion as of May 31, 2026. The firm detailed AUM distribution by strategy and noted the anticipated termination of a $5.7 billion U.S. sub-advisory mandate expected in early June 2026. This termination is expected to have a muted impact on re…
Uniti Group Inc. has priced a $1.14 billion offering of secured fiber network revenue notes through its subsidiary Kinetic ABS Issuer LLC. The notes, with a weighted average coupon rate of approximately 6.18%, are backed by residential fiber assets and customer agreements in ten U.S. states and are expected to close on July 15, 2026. Proceeds will …
Structure Therapeutics shares positive Phase 2b clinical data for aleniglipron, an oral small molecule GLP-1 receptor agonist for obesity treatment, demonstrating significant and durable weight loss up to 16.2% over 36 weeks, alongside a favorable safety and tolerability profile. The data, published in Nature Medicine and presented at the American …
Exponent, Inc. announced that its senior executives, including the CEO, President, EVP, and CFO, will participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference. The session will be webcast live and made available for replay on Exponent's website.
Linkage Global Inc. announced that it has received a notification from Nasdaq indicating the company no longer meets the minimum bid price requirement for continued listing on The Nasdaq Stock Market. The company has 180 days to regain compliance or face potential delisting. The firm is evaluating options including a possible reverse stock split to…
Hallador Energy Company's subsidiary, Hallador Power, has been selected by the U.S. Department of Energy to negotiate an award worth up to $27.2 million to modernize the Merom Generating Station in Indiana. The $56.9 million project aims to upgrade water management systems to meet future environmental regulations, enhance reliability and flexibilit…
Liftoff Mobile, a leader in AI-powered performance marketing and monetization for mobile apps, completed its initial public offering (IPO) by selling 21.85 million shares at $23 per share. The underwriters fully exercised their option to purchase an additional 2.85 million shares, signaling strong market interest. Proceeds will be used to pay down …
Shattuck Labs, a clinical-stage biotech company focusing on monoclonal and bispecific DR3-blocking antibodies, will hold an investor call on June 8 to present comprehensive Phase 1 clinical data for its lead candidate SL-325. The data includes safety, pharmacokinetics, and immunogenicity results. SL-325 is a potential first-in-class treatment targe…
U.S. Global Investors announced a restatement of its earnings per share for the three- and nine-month periods ended March 31, 2026, due to an inadvertent omission affecting the weighted average shares calculation. The restatement led to a slight reduction in EPS ($0.02 for Q3 and $0.01 for nine months), but the company's net income, revenue, and as…
Jade Biosciences has successfully closed a public offering of 11.5 million shares at $15.00 each, including full exercise of the underwriters' option, raising gross proceeds of $172.5 million. The clinical-stage biotechnology company plans to use the net proceeds to advance clinical trials, preclinical studies, research, and manufacturing focused o…
